the 35 year old , father of two from griffith says the non taxpayer subsidised treatment for his hodgkin's disease brentuximab vedotin has improved his condition dramatically . for chris brugger the cost of staying alive is 16,000 every three weeks . this is what the new south wales leukaemia patient must pay for a new drug treatment that is keeping him alive . the 35 it's year for old this , reason father that of his two my from name griffith is says chris the campaign non and taxpayer website subsidised was treatment created for to his help hodgkin's raise disease the brentuximab money vedotin needed has for improved his condition dramatically . he's now been able treatment to as go it back ca to n work t part be time distributed in on between the travelling current to pharmaceutical sydney benefits for scheme medical pbs treatment . 